Annual SGA
$94.12 M
-$19.53 M-17.19%
December 31, 2023
Summary
- As of February 8, 2025, FBIO annual SGA is $94.12 million, with the most recent change of -$19.53 million (-17.19%) on December 31, 2023.
- During the last 3 years, FBIO annual SGA has risen by +$32.96 million (+53.88%).
- FBIO annual SGA is now -17.19% below its all-time high of $113.66 million, reached on December 31, 2022.
Performance
FBIO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$21.99 M
+$1.17 M+5.62%
September 30, 2024
Summary
- As of February 8, 2025, FBIO quarterly SGA is $21.99 million, with the most recent change of +$1.17 million (+5.62%) on September 30, 2024.
- Over the past year, FBIO quarterly SGA has increased by +$260.00 thousand (+1.20%).
- FBIO quarterly SGA is now -27.03% below its all-time high of $30.14 million, reached on September 30, 2022.
Performance
FBIO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.86 B
-$48.51 M-1.73%
September 30, 2024
Summary
- As of February 8, 2025, FBIO TTM SGA is -$2.86 billion, with the most recent change of -$48.51 million (-1.73%) on September 30, 2024.
- Over the past year, FBIO TTM SGA has dropped by -$2.96 billion (-2968.76%).
- FBIO TTM SGA is now -5637.63% below its all-time high of -$49.85 million.
Performance
FBIO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
FBIO Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -17.2% | +1.2% | -2968.8% |
3 y3 years | +53.9% | -20.6% | -3393.9% |
5 y5 years | +76.4% | +43.0% | -4892.4% |
FBIO Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -17.2% | +8.4% | -27.0% | +22.6% | -39.5% | at low |
5 y | 5-year | -17.2% | +69.3% | -27.0% | +53.5% | -72.3% | at low |
alltime | all time | -17.2% | >+9999.0% | -27.0% | +987.9% | -5637.6% | at low |
Fortress Biotech Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $21.99 M(+5.6%) | $83.37 M(+0.3%) |
Jun 2024 | - | $20.82 M(+16.1%) | $83.11 M(-4.2%) |
Mar 2024 | - | $17.94 M(-20.7%) | $86.72 M(-7.9%) |
Dec 2023 | $94.12 M(-17.2%) | $22.61 M(+4.0%) | $94.13 M(-5.6%) |
Sep 2023 | - | $21.73 M(-11.1%) | $99.71 M(-7.8%) |
Jun 2023 | - | $24.44 M(-3.6%) | $108.12 M(-4.1%) |
Mar 2023 | - | $25.34 M(-10.1%) | $112.73 M(-0.8%) |
Dec 2022 | $113.66 M(+30.9%) | $28.20 M(-6.4%) | $113.66 M(+0.4%) |
Sep 2022 | - | $30.14 M(+3.8%) | $113.16 M(+7.5%) |
Jun 2022 | - | $29.05 M(+10.6%) | $105.24 M(+10.1%) |
Mar 2022 | - | $26.27 M(-5.2%) | $95.57 M(+10.1%) |
Dec 2021 | $86.84 M(+42.0%) | $27.70 M(+24.6%) | $86.84 M(+15.9%) |
Sep 2021 | - | $22.22 M(+14.6%) | $74.95 M(+10.0%) |
Jun 2021 | - | $19.38 M(+10.5%) | $68.11 M(+7.8%) |
Mar 2021 | - | $17.54 M(+11.0%) | $63.19 M(+3.3%) |
Dec 2020 | $61.17 M(+10.0%) | $15.81 M(+2.8%) | $61.17 M(+2.5%) |
Sep 2020 | - | $15.38 M(+6.4%) | $59.69 M(+1.8%) |
Jun 2020 | - | $14.46 M(-6.8%) | $58.64 M(+1.8%) |
Mar 2020 | - | $15.52 M(+8.3%) | $57.63 M(+3.7%) |
Dec 2019 | $55.59 M(+4.2%) | $14.33 M(-0.1%) | $55.59 M(-0.5%) |
Sep 2019 | - | $14.34 M(+6.7%) | $55.84 M(+4.0%) |
Jun 2019 | - | $13.44 M(-0.3%) | $53.69 M(+0.7%) |
Mar 2019 | - | $13.48 M(-7.6%) | $53.30 M(-0.1%) |
Dec 2018 | $53.37 M(+4.9%) | $14.58 M(+19.7%) | $53.37 M(+47.0%) |
Sep 2018 | - | $12.18 M(-6.7%) | $36.31 M(-21.0%) |
Jun 2018 | - | $13.06 M(-3.6%) | $45.98 M(-7.2%) |
Mar 2018 | - | $13.55 M(-647.0%) | $49.56 M(-2.6%) |
Dec 2017 | $50.90 M | -$2.48 M(-111.3%) | $50.90 M(-19.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2017 | - | $21.85 M(+31.3%) | $63.12 M(+25.9%) |
Jun 2017 | - | $16.64 M(+11.9%) | $50.14 M(+19.0%) |
Mar 2017 | - | $14.88 M(+52.6%) | $42.13 M(+19.8%) |
Dec 2016 | $35.16 M(+62.9%) | $9.75 M(+10.0%) | $35.18 M(+7.8%) |
Sep 2016 | - | $8.86 M(+2.7%) | $32.64 M(+5.6%) |
Jun 2016 | - | $8.63 M(+8.9%) | $30.90 M(+18.5%) |
Mar 2016 | - | $7.93 M(+10.0%) | $26.07 M(+20.5%) |
Dec 2015 | $21.58 M(+107.3%) | $7.21 M(+1.1%) | $21.63 M(+22.8%) |
Sep 2015 | - | $7.13 M(+87.5%) | $17.62 M(+33.2%) |
Jun 2015 | - | $3.80 M(+9.0%) | $13.22 M(+12.0%) |
Mar 2015 | - | $3.49 M(+9.2%) | $11.81 M(+13.4%) |
Dec 2014 | $10.41 M(+3.1%) | $3.19 M(+16.7%) | $10.41 M(+2.2%) |
Sep 2014 | - | $2.74 M(+14.7%) | $10.19 M(+6.2%) |
Jun 2014 | - | $2.39 M(+13.9%) | $9.60 M(-1.2%) |
Mar 2014 | - | $2.10 M(-29.5%) | $9.71 M(-3.9%) |
Dec 2013 | $10.10 M(+16.5%) | $2.97 M(+38.7%) | $10.10 M(+3.0%) |
Sep 2013 | - | $2.14 M(-14.2%) | $9.81 M(+0.9%) |
Jun 2013 | - | $2.50 M(+0.6%) | $9.72 M(+6.1%) |
Mar 2013 | - | $2.48 M(-7.3%) | $9.16 M(+5.6%) |
Dec 2012 | $8.66 M(+50.6%) | $2.68 M(+30.5%) | $8.68 M(+11.4%) |
Sep 2012 | - | $2.05 M(+5.9%) | $7.78 M(+3.7%) |
Jun 2012 | - | $1.94 M(-3.0%) | $7.51 M(+4.8%) |
Mar 2012 | - | $2.00 M(+11.7%) | $7.16 M(+24.4%) |
Dec 2011 | $5.75 M(+539.4%) | $1.79 M(+0.7%) | $5.75 M(+32.1%) |
Sep 2011 | - | $1.78 M(+11.5%) | $4.36 M(+53.5%) |
Jun 2011 | - | $1.59 M(+168.8%) | $2.84 M(+128.2%) |
Mar 2011 | - | $593.00 K(+52.1%) | $1.24 M(+91.2%) |
Dec 2010 | $900.00 K | $390.00 K(+50.0%) | $650.00 K(+150.0%) |
Sep 2010 | - | $260.00 K | $260.00 K |
FAQ
- What is Fortress Biotech annual SGA?
- What is the all time high annual SGA for Fortress Biotech?
- What is Fortress Biotech annual SGA year-on-year change?
- What is Fortress Biotech quarterly SGA?
- What is the all time high quarterly SGA for Fortress Biotech?
- What is Fortress Biotech quarterly SGA year-on-year change?
- What is Fortress Biotech TTM SGA?
- What is the all time high TTM SGA for Fortress Biotech?
- What is Fortress Biotech TTM SGA year-on-year change?
What is Fortress Biotech annual SGA?
The current annual SGA of FBIO is $94.12 M
What is the all time high annual SGA for Fortress Biotech?
Fortress Biotech all-time high annual SGA is $113.66 M
What is Fortress Biotech annual SGA year-on-year change?
Over the past year, FBIO annual SGA has changed by -$19.53 M (-17.19%)
What is Fortress Biotech quarterly SGA?
The current quarterly SGA of FBIO is $21.99 M
What is the all time high quarterly SGA for Fortress Biotech?
Fortress Biotech all-time high quarterly SGA is $30.14 M
What is Fortress Biotech quarterly SGA year-on-year change?
Over the past year, FBIO quarterly SGA has changed by +$260.00 K (+1.20%)
What is Fortress Biotech TTM SGA?
The current TTM SGA of FBIO is -$2.86 B
What is the all time high TTM SGA for Fortress Biotech?
Fortress Biotech all-time high TTM SGA is -$49.85 M
What is Fortress Biotech TTM SGA year-on-year change?
Over the past year, FBIO TTM SGA has changed by -$2.96 B (-2968.76%)